Labiotech.eu

Startup Scout 14 Jun 2019

This Biotech Reduces Drug Side Effects Using Silica Gel Implants

DelSiTech is a Finnish company developing injectable silica gel implants that release drugs slowly over time, causing fewer side effects and helping patients stick to their treatment regimen. Mission: To develop silica gels that slowly release drugs over time to treat conditions including HIV, hepatitis B, retinal disease and cancer. One big problem in chronic […]

June 14, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 13 Jun 2019

French Startup to Produce Sustainable Textile Dyes Using Microbes

Paris-based PILI has raised €3.6M that will take its technology to produce dyes through microbial fermentation to an industrial scale. Founded in 2015, PILI seeks to disrupt the unsustainable production of dyes. Just in the textile industry, dyes are a €8B market. However, the production of these chemicals relies on petrochemical processes that require toxic […]

June 13, 2019 - 2 minutesmins - By Clara Rodríguez Fernández

Interview 12 Jun 2019

How Vaccines Could One Day Beat HIV

Vaccines are humanity’s biggest achievement against infectious diseases. But could they defeat HIV, a particularly crafty virus? José Luis Cabero, CEO of Spanish biotech AELIX Therapeutics shared his experience developing an HIV vaccine at Labiotech Refresh in Barcelona. The concept of a vaccine is simple — priming the immune system against a pathogen so that […]

June 12, 2019 - 5 minutesmins - By Jonathan Smith

evotec tuberculosis treatment gates foundation

More News! 12 Jun 2019

Evotec to Reduce the Burden of Tuberculosis Treatment with €21M Grant

The Bill and Melinda Gates Foundation has granted the German biotech Evotec €21M ($23.8M) to discover drug combinations that can reduce the duration of tuberculosis treatment, which normally takes over six months. Evotec will use the money to test different drug combinations for tuberculosis in the preclinical stage. The partnership will last for five years, […]

June 12, 2019 - 2 minutesmins - By Jonathan Smith

genmab janssen blood cancer multiple myeloma

News and Trends 11 Jun 2019

Janssen and Genmab Team Up Again for Another Potential Cancer Blockbuster

Janssen and the Danish biotech Genmab will collaborate to develop a new antibody that could outperform their blockbuster cancer drug Darzalex in certain types of blood cancer. Genmab will develop the antibody treatment until it completes clinical proof-of-concept studies in the blood cancers multiple myeloma and diffuse large B-cell lymphoma. At that point, Janssen will […]

June 11, 2019 - 2 minutesmins - By Jonathan Smith

In Depth 11 Jun 2019

Gamma Delta T Cells: A New Hope Against Cancer

A new wave of therapies based on a unique type of immune cells, called gamma delta T cells, has the potential to treat cancer with stronger responses and fewer side effects. Immunotherapies based on T cells are becoming a huge trend in the treatment of cancer, especially CAR-T cells. These genetically-modified T cells have shown […]

June 11, 2019 - 5 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 10 Jun 2019

The 10 Biotech Companies in London to Keep an Eye on in 2019

Which biotechs will be stealing the show this year? These are some of the most exciting biotech companies in London right now. London is undoubtedly one of the biggest hubs for biotech companies in the U.K. and in Europe. The British capital was the one that received the most life sciences investment in Europe in […]

June 10, 2019 - 5 minutesmins - By Clara Rodríguez Fernández

Expert Advice 8 Jun 2019

Why Sticking to Your Beliefs is Important for Biotech Success

Galapagos is an undeniable success story. Set up in 1999, it is now one of the largest and most successful biotechs in Europe. A key driving force behind the company is Onno van de Stolpe, its founder and CEO. After doing an internship at Biogen while at university, van de Stolpe knew he wanted to […]

June 8, 2019 - 11 minutesmins - By Helen Albert

News and Trends 7 Jun 2019

CRISPR Therapeutics and Vertex Seal Deal Worth up to €890M

The US giant Vertex Pharmaceuticals is expanding an existing collaboration with the Swiss company CRISPR Therapeutics, paying up to €890M ($1B) to develop treatments for genetic diseases causing muscle weakness using the gene editing tool CRISPR/Cas9. The deal includes €155M ($175M) paid upfront, and potential future payments based on achieving developmental milestones. In exchange, Vertex […]

June 7, 2019 - 2 minutesmins - By Jonathan Smith

stockholm diabetes treatment biocrine eye

Startup Scout 7 Jun 2019

This Biotech Transplants Cells into the Eye to Personalize Diabetes Treatments

Up north in Stockholm, the Swedish company Biocrine aims to personalize diabetes treatments by screening drugs in pancreatic cells that have been transplanted into the eye. Mission: To test new drugs for type 1 and type 2 diabetes on pancreatic cells transplanted into the eye, where the cells can thrive and be easily monitored with […]

June 7, 2019 - 4 minutesmins - By Jonathan Smith

inflarx trial inflammatory disease fail skin

More News! 6 Jun 2019

Shares Drop 90% as Antibody for Inflammatory Skin Disease Fails Phase II

The German company InflaRx has seen its shares on the Nasdaq plummet after announcing that its treatment for an inflammatory skin disease failed to beat the placebo in a phase IIb trial. The trial had enrolled 179 patients with hidradenitis suppurativa, an incurable condition causing painful lumps on the skin. By the 16th week of […]

June 6, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 5 Jun 2019

Highlights from European Biotech at ASCO 2019

European biotech companies gathered in Chicago, USA, to share the latest advances in cancer research at the biggest cancer conference of the year, ASCO 2019. This year’s conference has drawn fewer big blockbuster headlines than other years, but there was plenty to see nonetheless. There were results from many different clinical trials by big pharma […]

June 5, 2019 - 5 minutesmins - By Jonathan Smith

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

This Biotech Reduces Drug Side Effects Using Silica Gel Implants

French Startup to Produce Sustainable Textile Dyes Using Microbes

How Vaccines Could One Day Beat HIV

Evotec to Reduce the Burden of Tuberculosis Treatment with €21M Grant

Janssen and Genmab Team Up Again for Another Potential Cancer Blockbuster

Gamma Delta T Cells: A New Hope Against Cancer

The 10 Biotech Companies in London to Keep an Eye on in 2019

Why Sticking to Your Beliefs is Important for Biotech Success

CRISPR Therapeutics and Vertex Seal Deal Worth up to €890M

This Biotech Transplants Cells into the Eye to Personalize Diabetes Treatments

Shares Drop 90% as Antibody for Inflammatory Skin Disease Fails Phase II

Highlights from European Biotech at ASCO 2019

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!